The FDA's Mifepristone Decision Has Baffled Both Sides

The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret the decision. Could this be a sign that the Trump administration isn’t interested in taking federal...

Redirecting to full article...